Quality by design approach to optimize the formulation variables influencing the characteristics of biodegradable intramuscular in-situ gel loaded with alendronate sodium for osteoporosis-Reference-Cited by-同舟云学术

Quality by design approach to optimize the formulation variables influencing the characteristics of biodegradable intramuscular in-situ gel loaded with alendronate sodium for osteoporosis

Published:2018-06-01 Issue:6 Volume:13 Page:e0197540
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Hosny Khaled Mohamed^ORCID,Rizg Waleed Yousof

Funder

Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference33 articles.

1. Enteric-coated alendronate sodium nanoliposomes: a novel formulations to overcome barriers for the treatment of osteoporosis;KM Hosny;Expert Opinion on Drug Delivery,2013

2. Ten years' experience with alendronate for osteoporosis in postmenopausal women;H G Bone;New England Journal of Medicine,2004

3. Therapeutic equivalence of alendronate 70 mg once-weekly and alendronate 10 mg daily in the treatment of osteoporosis;T Schnitzer;Aging Clinical and Experimental Research,2000

4. Alendronate Sodium as Enteric Coated Solid Lipid Nanoparticles; Preparation, Optimization, and In Vivo Evaluation to Enhance Its Oral Bioavailability;KM Hosny;PLOS ONE,2016

5. Role of Alendronate and Risedronate in Preventing and Treating Osteoporosis;ML Peters;Cleve Clin J Med,2001

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmaceutical product development: a “quality by design” (QbD) approach;Dosage Forms, Formulation Developments and Regulations;2024

2. Polymeric in situ forming depots for long-acting drug delivery systems;Advanced Drug Delivery Reviews;2023-09

3. Development of depot PLGA-based in-situ implant of Linagliptin: Sustained release and glycemic control;Saudi Pharmaceutical Journal;2023-04

4. Nanotechnology for Targeted Drug Delivery to Treat Osteoporosis;Current Drug Targets;2023-01

5. Hydrogel-based delivery system applied in the local anti-osteoporotic bone defects;Frontiers in Bioengineering and Biotechnology;2022-11-11